MC2107A1 - Derives d'acides amines - Google Patents

Derives d'acides amines

Info

Publication number
MC2107A1
MC2107A1 MC902123A MC2123A MC2107A1 MC 2107 A1 MC2107 A1 MC 2107A1 MC 902123 A MC902123 A MC 902123A MC 2123 A MC2123 A MC 2123A MC 2107 A1 MC2107 A1 MC 2107A1
Authority
MC
Monaco
Prior art keywords
amino acid
acid derivatives
derivatives
amino
acid
Prior art date
Application number
MC902123A
Other languages
English (en)
Inventor
Branca Quirico
Peter Marki Hans
Neidhart Werner
Ramuz Henri
Wostl Wolfgang
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC2107A1 publication Critical patent/MC2107A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/01Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/34Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0821Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Public Health (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MC902123A 1989-04-05 1990-03-29 Derives d'acides amines MC2107A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH129089 1989-04-05

Publications (1)

Publication Number Publication Date
MC2107A1 true MC2107A1 (fr) 1991-03-11

Family

ID=4206973

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902123A MC2107A1 (fr) 1989-04-05 1990-03-29 Derives d'acides amines

Country Status (15)

Country Link
US (1) US5140011A (fr)
EP (1) EP0391179A3 (fr)
JP (1) JPH02290836A (fr)
KR (1) KR900016114A (fr)
AU (1) AU5252290A (fr)
CA (1) CA2012901A1 (fr)
FI (1) FI901730A0 (fr)
HU (1) HUT53598A (fr)
IL (1) IL93955A0 (fr)
MC (1) MC2107A1 (fr)
NO (1) NO901533L (fr)
NZ (1) NZ233082A (fr)
PT (1) PT93658A (fr)
YU (1) YU65690A (fr)
ZA (1) ZA902444B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2209937B (en) * 1987-09-21 1991-07-03 Depiopharm S A Water insoluble polypeptides
US5250517A (en) * 1987-10-06 1993-10-05 Hoffmann-La Roche Inc. Renin inhibiting compounds
CA1328333C (fr) * 1988-03-04 1994-04-05 Quirico Branca Derives d'acide amine
US5430041A (en) * 1991-05-10 1995-07-04 Hoffmann-La Roche Inc. Amino acid derivatives having antiviral activity
ATE172717T1 (de) 1992-08-25 1998-11-15 Searle & Co Hydroxyethylaminosulfonamide verwendbar als inhibitoren retroviraler proteasen
US7141609B2 (en) 1992-08-25 2006-11-28 G.D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
US5326773A (en) * 1992-10-29 1994-07-05 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU1596895A (en) * 1994-01-25 1995-08-08 G.D. Searle & Co. Malarial aspartic protease inhibitors
US5777153A (en) * 1994-07-08 1998-07-07 Gilead Sciences, Inc. Cationic lipids
US6093816A (en) * 1996-06-27 2000-07-25 Isis Pharmaceuticals, Inc. Cationic lipids
AU4862799A (en) 1998-07-08 2000-02-01 G.D. Searle & Co. Retroviral protease inhibitors
JP2008266292A (ja) * 2007-03-23 2008-11-06 Sumitomo Chemical Co Ltd ベンゾアゾール化合物の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8322414D0 (en) * 1983-08-19 1983-09-21 Szelke M Renin inhibitors
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
US4652551A (en) * 1984-06-22 1987-03-24 Abbott Laboratories Renin inhibiting compounds
US4880781A (en) * 1984-08-06 1989-11-14 The Upjohn Company Renin inhibitory peptides containing an N-alkyl-histidine moiety
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
IL81234A (en) * 1986-01-16 1992-09-06 Abbott Lab Peptidylaminodiols,process for their preparation and pharmaceutical compositions comprising them
US4851387A (en) * 1986-10-14 1989-07-25 Banyu Pharmaceutical Co., Ltd. 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
US4758584A (en) * 1987-02-05 1988-07-19 Ciba-Geigy Corporation Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
DK523288A (da) * 1987-10-06 1989-04-07 Hoffmann La Roche Aminosyrederivater

Also Published As

Publication number Publication date
ZA902444B (en) 1990-12-28
EP0391179A3 (fr) 1991-04-03
NZ233082A (en) 1992-11-25
JPH02290836A (ja) 1990-11-30
KR900016114A (ko) 1990-11-12
NO901533L (no) 1990-10-08
YU65690A (en) 1991-10-31
IL93955A0 (en) 1990-12-23
US5140011A (en) 1992-08-18
NO901533D0 (no) 1990-04-04
FI901730A0 (fi) 1990-04-05
HU902037D0 (en) 1990-08-28
EP0391179A2 (fr) 1990-10-10
PT93658A (pt) 1990-11-20
HUT53598A (en) 1990-11-28
CA2012901A1 (fr) 1990-10-05
AU5252290A (en) 1990-11-22

Similar Documents

Publication Publication Date Title
MC2040A1 (fr) Derives d'acides amines
MC2022A1 (fr) Derives d'acides amines
MC2151A1 (fr) Derives d'acides amines
MC2106A1 (fr) Derives d'aminoacides
MC2103A1 (fr) Derives d'aminoacides
MA26449A1 (fr) Derives d'acides amines .
DE59008394D1 (de) Aminosäureamid-Derivate.
NO920417D0 (no) Aminosyrederivater
DK340088D0 (da) Aminosyrederivater
DE69025723D1 (de) N-(Pyrrolo(2-3-d)pyrimidin-3-ylacyl)-Glutaminsäurederivate
FR2609998B1 (fr) Nouvelles substances antioxydantes derivees d'acides amines
MC1985A1 (fr) Derives d'acides amines
MC2107A1 (fr) Derives d'acides amines
DK0425925T3 (da) Substituerede aminosyreamid-derivater samt deres fremstilling og anvendelse
MC2264A1 (fr) Derives d'aminoacides
IT9021958A0 (it) Procedimento di purificazione dell'ammoniaca
MC1981A1 (fr) Derives d'acides catechol carboxyliques
PT75949A (fr) Procede pour la preparation de derives d'acides amines en n-(vinblastinoil-23)
MC2109A1 (fr) Dérivés d'acides aminés
DE69018816T2 (de) Aminosäurederivate.
FR2508036B1 (fr) Nouveaux derives d'acides amines na-3-cyano-propanoiques et application de ces derives
KR900007857A (ko) 1,4,2-옥사자포스폴리딘-4-아세트산, 2-알콕시-2-옥사이드의 아민염
DE59002430D1 (de) Cyclopropanoylaminosäureamid-Derivate.
NO924423D0 (no) Aminosyrederivater
FR2596762B1 (fr) Derives d'acides nucleiques

Legal Events

Date Code Title Description
YP Annual fee paid